Cargando…
Does SGLT1 inhibition add to the benefits of SGLT2 inhibition in the prevention and treatment of heart failure?
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712026/ https://www.ncbi.nlm.nih.gov/pubmed/35979811 http://dx.doi.org/10.1093/eurheartj/ehac417 |
| _version_ | 1784841707554078720 |
|---|---|
| author | Pitt, Bertram Bhatt, Deepak L Metra, Marco |
| author_facet | Pitt, Bertram Bhatt, Deepak L Metra, Marco |
| author_sort | Pitt, Bertram |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9712026 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97120262022-12-02 Does SGLT1 inhibition add to the benefits of SGLT2 inhibition in the prevention and treatment of heart failure? Pitt, Bertram Bhatt, Deepak L Metra, Marco Eur Heart J Viewpoint Oxford University Press 2022-08-18 /pmc/articles/PMC9712026/ /pubmed/35979811 http://dx.doi.org/10.1093/eurheartj/ehac417 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of European Society of Cardiology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| spellingShingle | Viewpoint Pitt, Bertram Bhatt, Deepak L Metra, Marco Does SGLT1 inhibition add to the benefits of SGLT2 inhibition in the prevention and treatment of heart failure? |
| title | Does SGLT1 inhibition add to the benefits of SGLT2 inhibition in the prevention and treatment of heart failure? |
| title_full | Does SGLT1 inhibition add to the benefits of SGLT2 inhibition in the prevention and treatment of heart failure? |
| title_fullStr | Does SGLT1 inhibition add to the benefits of SGLT2 inhibition in the prevention and treatment of heart failure? |
| title_full_unstemmed | Does SGLT1 inhibition add to the benefits of SGLT2 inhibition in the prevention and treatment of heart failure? |
| title_short | Does SGLT1 inhibition add to the benefits of SGLT2 inhibition in the prevention and treatment of heart failure? |
| title_sort | does sglt1 inhibition add to the benefits of sglt2 inhibition in the prevention and treatment of heart failure? |
| topic | Viewpoint |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712026/ https://www.ncbi.nlm.nih.gov/pubmed/35979811 http://dx.doi.org/10.1093/eurheartj/ehac417 |
| work_keys_str_mv | AT pittbertram doessglt1inhibitionaddtothebenefitsofsglt2inhibitioninthepreventionandtreatmentofheartfailure AT bhattdeepakl doessglt1inhibitionaddtothebenefitsofsglt2inhibitioninthepreventionandtreatmentofheartfailure AT metramarco doessglt1inhibitionaddtothebenefitsofsglt2inhibitioninthepreventionandtreatmentofheartfailure |